Reported by 1 source

The short version

  • Henri Kagan and Kenso Soai were awarded the Nobel Prize in Chemistry for their work on molecular chirality, which allows for the precise synthesis of single-handed molecules.
  • Their research enables pharmaceutical companies to produce drugs with fewer side effects by isolating specific molecular forms rather than using mixed racemates.
  • While the findings do not fully explain why life evolved a preference for one molecular hand, they provide a mechanism for how such asymmetry could arise spontaneously.

The Royal Swedish Academy of Sciences has awarded the Nobel Prize in Chemistry to Henri Kagan and Kenso Soai for their fundamental contributions to understanding molecular chirality. The announcement, made on October 7, recognizes decades of research that have resolved a long-standing puzzle regarding why biological systems favor one mirror-image form of molecules over another. This phenomenon, known as homochirality, is essential to life as we know it, yet its origins and mechanisms remained elusive for much of the twentieth century.

Chirality refers to the property of molecules that exist in two forms which are non-superimposable mirror images of each other, similar to human hands. While these chiral forms may appear structurally identical, they can exhibit vastly different chemical behaviors and biological effects. For instance, the molecule carvone smells like mint in one configuration and like caraway seeds in the other. In living organisms, this asymmetry is strict: sugars in DNA are exclusively right-handed, while the amino acids that build proteins are predominantly left-handed.

News Journal

For many years, scientists struggled to replicate this natural selectivity in laboratory settings. Standard chemical reactions typically produced equal amounts of both mirror-image forms, resulting in a fifty-fifty mixture known as a racemate. This lack of control posed significant challenges for the pharmaceutical industry, where the two forms of a drug molecule can have drastically different impacts on the human body. One version might provide therapeutic relief, while its mirror image could be inactive or even cause harmful side effects.

Henri Kagan’s pivotal contribution came in 1986, when he demonstrated that introducing an asymmetrical catalyst into a chemical reaction could influence the handedness of the resulting molecules. He discovered that this effect was nonlinear; a slight imbalance in the catalyst could lead to a disproportionately large imbalance in the final product. This finding provided a crucial tool for chemists seeking to steer reactions toward producing a specific chiral form, rather than an equal mix.

Kenso Soai built upon this foundation by developing autocatalytic reactions that amplify molecular asymmetry without the need for external chiral influences. In 2003, he published findings describing a reaction in which the product itself acts as a catalyst, reinforcing its own formation and leading to a vast majority of one mirror image. This process allows for the spontaneous creation of highly pure chiral molecules, a feat that had previously been thought impossible without pre-existing chiral templates.

The practical implications of these discoveries are profound for modern medicine. Historically, many drugs were sold as racemates because separating the individual forms was difficult and expensive. The ability to selectively synthesize single-handed molecules has allowed pharmaceutical developers to create more targeted therapies with improved safety profiles. By eliminating the inactive or harmful mirror image, manufacturers can reduce adverse reactions and increase the efficacy of treatments.

Beyond pharmacology, the work of Kagan and Soai offers valuable insights into the origins of life. Although their research does not definitively explain why nature chose right-handed sugars and left-handed amino acids billions of years ago, it provides a plausible mechanism for how such asymmetry could have emerged from a symmetric starting point. The autocatalytic processes described by Soai suggest that small initial imbalances could be amplified over time, potentially seeding the homochirality observed in all known life forms.

Experts in the field have praised the award as a recognition of work that bridges fundamental chemistry and practical application. Rigoberto Hernandez, president of the American Chemical Society, noted that modern medicines would not exist without these advances in controlling molecular handedness. The ability to manipulate chirality is now considered critical for developing new drugs, as it allows scientists to precisely control how therapeutic agents interact with biological systems.

The Nobel committee emphasized that this achievement marks a significant milestone in chemical science, echoing the processes that shaped life’s building blocks eons ago. While questions remain about the ultimate origins of biological chirality, the tools developed by Kagan and Soai have transformed how chemists approach synthesis. Their legacy lies not only in solving a theoretical mystery but in providing the means to create safer, more effective medicines for millions of patients worldwide.

As research continues, the principles established by these laureates will likely guide future innovations in materials science and biology. The distinction between left- and right-handed molecules is no longer just a curiosity of nature but a manageable variable in chemical engineering. This shift underscores the importance of fundamental research in driving technological progress and improving public health outcomes through more precise scientific understanding.

Sources behind this briefing

Go to the original reporting

  • Smithsonian Magazine↗Two Chemists Win Nobel Prize for Unraveling a Mystery of Molecular 'Handedness,' Helping Drugmakers Develop Safer Medications